NU7441 (KU-57788)

Catalog No.S2638

NU7441 (KU-57788) Chemical Structure

Molecular Weight(MW): 413.49

NU7441 (KU-57788) is a highly potent and selective DNA-PK inhibitor with IC50 of 14 nM and also inhibits PI3K with IC50 of 5 μM in cell-free assays. It reduces the frequency of NHEJ while increasing the rate of HDR following Cas9-mediated DNA cleavage.

Size Price Stock Quantity  
USD 70 In stock
USD 120 In stock
USD 370 In stock
USD 970 In stock
Bulk Discount

Free Overnight Delivery on orders over $ 500
Next day delivery by 10:00 a.m. Order now.

Cited by 25 Publications

6 Customer Reviews

  • Cells were treated with cisplatin under the following conditions: pretreatment with Nu7026 (Nu7026, 26) or Nu7441 (Nu7441, 41). Before DNA damage, wortmannin was applied at 100 nM for 30 min, Nu7026 at 10 uM for 1 h, Nu7441 at 1 uM for 1 h. Accompanying quantifications of the adjusted nucleolar EU fluorescence are shown. Each condition was normalized to cells treated with DMSO or indicated inhibitors without DNA damaging treatment. Two-way ANOVA was followed by Holm-Sidak's test for the comparison of cells with and without inhibitors. *, **, *** represent P ≤ 0.05, 0.01, 0.001, respectively.

    Nucleic Acids Res 2013 41(15), 7378-86. NU7441 (KU-57788) purchased from Selleck.

    Confocal immunostaining of S2056 phosphorylation of DNA-PKcs following radiation in HEK 293T and p18CycE-expressing cells.

    Nucleic Acids Res 2013 41, 10157-69. NU7441 (KU-57788) purchased from Selleck.

  • (C) Microirradiation live-cell microscopy of U2OS cells stably expressing mEGFP-MacroD2 full-length construct and treated with KU55933 10 μM, VE-821 1 μM, NU7441 1 μM or DMSO. Scale bar, 10 μm.

    Nucleic Acids Res, 2017, 45(1):244-254. NU7441 (KU-57788) purchased from Selleck.

    (C) Immunohistochemically detection of Cleaved Caspase-3 48 h after treatment to measure apoptosis in vivo, induced levels of apoptosis in xenografts treated with radiation in combination with DNA-PKcsi and HT compared to radiation alone. Necrotic areas were observed in xenograft of triple treatment. DNA-PKcsi:NU7441

    Oncotarget, 2016, 7(40): 65504-65513. NU7441 (KU-57788) purchased from Selleck.

  • Validation of activity and specificity of chemical inhibitors of; ATM, ATR, and DNAPK. H460 cells were treated with 1 uM camptothecin (CPT) or 20 ug/ml bleomycin for 1 h in the presence of the indicated inhibitors: DNAPK-i1—NU7026, DNAPK-i2—NU7441. MSH6, fibrillarin, and tubulin were used as loading controls.Effects of DNAPK inhibitors on its autophosphorylation in bleomycin-treated cells.

    Toxicol Sci 2014 10.1093/toxsci/kfu207. NU7441 (KU-57788) purchased from Selleck.

    After starved in serum-free medium for 24h,A549 cells incubated with the indicated concentrations of NU-7441 for 3h,followed by 20-minute stimolation of 100ng/ml EGF.

    Dr. Zhang of Tianjin Medical University. NU7441 (KU-57788) purchased from Selleck.

Purity & Quality Control

Choose Selective DNA-PK Inhibitors

Biological Activity

Description NU7441 (KU-57788) is a highly potent and selective DNA-PK inhibitor with IC50 of 14 nM and also inhibits PI3K with IC50 of 5 μM in cell-free assays. It reduces the frequency of NHEJ while increasing the rate of HDR following Cas9-mediated DNA cleavage.
Targets
DNA-PK [1]
(Cell-free assay)
14 nM
In vitro

NU7441 increases the persistence of γH2AX foci after ionizing radiation–induced or etoposide-induced DNA damage. NU7441 (0.5 μM or 1 μM) appreciably increases G2-M accumulation induced by ionizing radiation, etoposide, and doxorubicin in both SW620 and LoVo cells. [2] NU7441 causes persistence of doxorubicin- and ionising radiation-induced DNA double-strand break and also slightly decreases homologous recombination activity DNA-PK-proficient M059-Fus-1 and DNA-PK-deficient M059 J human tumour cells. [3] NU7441 inhibits UV-induced RPA p34 hyperphosphorylation in a dose-dependent manner both in cells lacking and cells expressing polymerase η. [4] NU7441 increases levels of fludarabine-induced γH2AX foci and correspondingly decreased fludarabine-induced cell death in chronic lymphocytic leukemia cells. [5] NU7441 also inhibits mitoxantrone-induced DNA-PKcs autophosphorylation and repair in chronic lymphocytic leukemia cells. [6] It reduces the frequency of NHEJ while increasing the rate of HDR following Cas9-mediated DNA cleavage[7].

Cell Data
Cell Lines Assay Type Concentration Incubation Time Formulation Activity Description PMID
NCI-H1770 M4HPbWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NGXlRXhKSzVyPUCuNFIyPDNizszN MoPpV2FPT0WU
A172 M4HvOWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NGfONnRKSzVyPUCuNVU{OTZizszN NILj[oFUSU6JRWK=
NCI-H526 NF\WXHpIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NYjCXZhkUUN3ME2wMlI5PDB5IN88US=> Ml;1V2FPT0WU
HDLM-2 M4Cye2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MorXTWM2OD1yLkOyN|Q2KM7:TR?= NYflV3gzW0GQR1XS
HuO-3N1 MXnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NVfReFhHUUN3ME2wMlQ3PjN4IN88US=> MYXTRW5ITVJ?
NCI-SNU-1 NXPXcWpXT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NH;hcFdKSzVyPUCuOlA6QTRizszN NILsWI5USU6JRWK=
SK-N-AS NXLRbVhST3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MX;JR|UxRTBwNkKyNVYh|ryP Mkf3V2FPT0WU
LoVo M4[1T2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MkKyTWM2OD1yLki2O|Q6KM7:TR?= NUfRV3BDW0GQR1XS
LAMA-84 MnTLS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? M3HpR2lEPTB;MD65PFg{OyEQvF2= MUDTRW5ITVJ?
CTB-1 NFiwRm9Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NILYTIZKSzVyPUGuNVE2PDZizszN M{TPfnNCVkeHUh?=
KP-N-YS MmLsS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NGX5WG5KSzVyPUGuNVQzOzFizszN NGXYUGpUSU6JRWK=
HH M{KwRWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MnnsTWM2OD1zLkG4NFk{KM7:TR?= MUjTRW5ITVJ?
CHL-1 NY\5V4twT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NFfEZ3VKSzVyPUGuNlE{PjhizszN NUjmN3BXW0GQR1XS
NB7 MVPHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NEPIPJhKSzVyPUGuNlQ4PDVizszN MnnZV2FPT0WU
HL-60 MkLyS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? M1m3cWlEPTB;MT6zPFE6KM7:TR?= NVjMV|JnW0GQR1XS
639-V NI\ENZdIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NWDhVoRSUUN3ME2xMlQ1OTJ6IN88US=> M3HtXXNCVkeHUh?=
NCI-H1793 MYjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NGnE[FNKSzVyPUGuOFU5PCEQvF2= M1fXSHNCVkeHUh?=
NEC8 NGLDd|lIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NIO1bnpKSzVyPUGuOVU{PSEQvF2= M4LPRnNCVkeHUh?=
PA-1 MUjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NGL2NJdKSzVyPUGuOVgzQTRizszN M1K2RnNCVkeHUh?=
D-423MG NGfnTGNIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MnnYTWM2OD1zLk[5N|YyKM7:TR?= NH2zZZZUSU6JRWK=
NCI-H292 MXfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MlrCTWM2OD1zLke0NFE{KM7:TR?= NH3rRnRUSU6JRWK=
SK-MEL-1 NE\JbGlIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MoXrTWM2OD1zLke5OFc6KM7:TR?= NXWyZ3BGW0GQR1XS
LB2241-RCC NVf3cpRTT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NX;IOI1tUUN3ME2yMlE1OTR4IN88US=> MnjBV2FPT0WU
SK-MEL-3 MWfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NXLuSFhbUUN3ME2yMlE3PDlizszN NXfwV5NDW0GQR1XS
MHH-PREB-1 MoDNS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NUniSlAxUUN3ME2yMlE3PjB7IN88US=> MYrTRW5ITVJ?
BFTC-905 NXfJPYgyT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= Ml[4TWM2OD1{LkG2Olg4KM7:TR?= NVnXNoM4W0GQR1XS
Ramos-2G6-4C10 NXnnUnRXT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NUPkdHR7UUN3ME2yMlE6QTB7IN88US=> MUnTRW5ITVJ?
G-361 NUfMS5ZmT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MUnJR|UxRTJwMkG2PEDPxE1? NGnhfI1USU6JRWK=
MOLT-4 MXrHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NHXHS2dKSzVyPUKuNlE5QDhizszN MWfTRW5ITVJ?
DEL MUHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NXjMRWV5UUN3ME2yMlM2PTZ2IN88US=> MoLyV2FPT0WU
MV-4-11 NY\1SmpwT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NYPWdG9wUUN3ME2yMlM4OzlizszN NG\0fo5USU6JRWK=
SK-NEP-1 MVLHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MVjJR|UxRTJwM{i3PFMh|ryP NH3BeoZUSU6JRWK=
RS4-11 NVrLcWZIT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NGXmfGhKSzVyPUKuOVYxOjNizszN NYLuOIhvW0GQR1XS
HuH-7 NFfTVldIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MmHBTWM2OD1{LkW2O|AzKM7:TR?= MnP3V2FPT0WU
A101D MVfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NH\NbZdKSzVyPUKuOlE{OzhizszN MYTTRW5ITVJ?
KG-1 M3L0eWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MWPJR|UxRTJwNke5NlQh|ryP NUPyWWM6W0GQR1XS
KALS-1 NHTIbnRIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NXWzWml4UUN3ME2yMlY6PjN|IN88US=> MUTTRW5ITVJ?
VMRC-RCZ MYXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? M1\ueWlEPTB;Mj63O|MzQCEQvF2= M3voRXNCVkeHUh?=
SK-UT-1 NX7NWlVJT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MXHJR|UxRTNwMUWzNUDPxE1? NGjHPJpUSU6JRWK=
SW962 MXjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? M1HjWmlEPTB;Mz6yNFM2OiEQvF2= NYnGO3o2W0GQR1XS
DBTRG-05MG NWHZOFlrT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MXXJR|UxRTNwMkiwPFUh|ryP M4nLUHNCVkeHUh?=
PANC-08-13 MV;Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NHP0RpdKSzVyPUOuOFEzPzhizszN MYLTRW5ITVJ?
QIMR-WIL NYfB[YVUT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NYrYSYdHUUN3ME2zMlQyOzRzIN88US=> Mnr4V2FPT0WU
SK-MEL-30 M4iwWGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NWnSeYhIUUN3ME2zMlQzPTl6IN88US=> Mk\EV2FPT0WU
697 M3HxeGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NH\oSFBKSzVyPUOuOFQ6QTNizszN M1u3W3NCVkeHUh?=
NY MkDiS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MV7JR|UxRTNwNEWwNlIh|ryP NHOyZ5dUSU6JRWK=
ES7 NULM[FVLT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= M2ntWWlEPTB;Mz60OlczQSEQvF2= NGPm[o1USU6JRWK=
JVM-3 NIH4OlNIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MmfqTWM2OD1|LkS4NFc4KM7:TR?= NEnVOJFUSU6JRWK=
U031 MlrJS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? M{TaOWlEPTB;Mz61PVM3QCEQvF2= NEnpZoZUSU6JRWK=
BHT-101 NHizOY1Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MUHJR|UxRTNwNUm5PFUh|ryP MWjTRW5ITVJ?
8305C NXXpfWZIT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= M1j5NGlEPTB;Mz62NVc{PiEQvF2= MofpV2FPT0WU
MG-63 MknKS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MnToTWM2OD1|Lk[yOlc3KM7:TR?= M2ey[XNCVkeHUh?=
NOS-1 MULHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MVfJR|UxRTNwNkWzNVIh|ryP MoTHV2FPT0WU
YH-13 MVLHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MVHJR|UxRTNwOEexPFkh|ryP MWXTRW5ITVJ?
LXF-289 NE\4cXlIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MmTJTWM2OD1|LkmxNFQyKM7:TR?= M4LscnNCVkeHUh?=
GOTO MXjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MmfRTWM2OD1|LkmxOFkh|ryP Mlq5V2FPT0WU
EKVX MXHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NVvxfVlpUUN3ME20MlIzPTJ2IN88US=> NH\G[oZUSU6JRWK=
CAL-51 MYXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MUjJR|UxRTRwMkS4OVQh|ryP M3XHTnNCVkeHUh?=
AN3-CA MWnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? M2fuWmlEPTB;ND6yOVgyOyEQvF2= MXLTRW5ITVJ?
IA-LM M2TsTmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 M2PpPGlEPTB;ND6yO|k{PSEQvF2= NW\q[5lRW0GQR1XS
KU-19-19 NX;nclJnT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= Mon2TWM2OD12LkOyPVIyKM7:TR?= M1q3cnNCVkeHUh?=
A704 M{jPbWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NXTMSmZLUUN3ME20MlQxQDh6IN88US=> NXy1XGR3W0GQR1XS
RH-18 NWi2Rmh{T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NHvBW|dKSzVyPUSuOFQ6PTNizszN M{LH[nNCVkeHUh?=
IST-MEL1 MXXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MVPJR|UxRTRwNUiyOlMh|ryP MXHTRW5ITVJ?
LU-134-A MXvHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MmfFTWM2OD12LkW5Olg2KM7:TR?= NEjwWo9USU6JRWK=
SF126 NVTRZWpbT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MWPJR|UxRTRwNkC3NVUh|ryP MkK3V2FPT0WU
EFO-27 NXu3eVg6T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MX;JR|UxRTRwNk[1NlUh|ryP NWTMd4Y5W0GQR1XS
SN12C MVHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NWfPO|ZzUUN3ME20MlcyQDl6IN88US=> NHnzTZVUSU6JRWK=
L-363 NV7KSZo{T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NYm2e2hvUUN3ME20Mlc4OTF4IN88US=> NF\KXpRUSU6JRWK=
MEL-HO MlX3S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? M1TGTGlEPTB;ND63O|k5QSEQvF2= MVHTRW5ITVJ?
TYK-nu MUfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? M37MUmlEPTB;ND64NFEzQCEQvF2= NWG1R5FuW0GQR1XS
MDA-MB-415 M1PCPWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 Mn;LTWM2OD13LkCwN|E1KM7:TR?= MnLUV2FPT0WU
HCC70 NEnWPJRIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NH;Ec2ZKSzVyPUWuNFM6OzlizszN NFzOfnZUSU6JRWK=
IGROV-1 M1fj[Gdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NHfZWZdKSzVyPUWuNlUzQTJizszN Mlz5V2FPT0WU
NCI-H1355 NVi4S2R5T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= M2TqN2lEPTB;NT6yPVYh|ryP M1HIUHNCVkeHUh?=
23132-87 NX76VGpnT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= M{SzN2lEPTB;NT6zNlAzPCEQvF2= Ml7XV2FPT0WU
NB69 MnLxS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NX7nNlFoUUN3ME21MlMzPDJizszN MVfTRW5ITVJ?
HSC-2 NHLTZ5RIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NUHjXYxWUUN3ME21MlQyPzd|IN88US=> NW\0c3VjW0GQR1XS
KYSE-410 NYjOSod2T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MX\JR|UxRTVwNEe2N|Yh|ryP MnT6V2FPT0WU
GCIY MVjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NGf0[lJKSzVyPUWuOVE{PzhizszN M4XXXHNCVkeHUh?=
A427 M1Pn[mdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NXn4SnpJUUN3ME21MlU{PjZzIN88US=> M{X5XHNCVkeHUh?=
ChaGo-K-1 MVnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NX\IWJBxUUN3ME21MlU3PTl7IN88US=> MmjMV2FPT0WU
PFSK-1 Mmj2S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? M1uxW2lEPTB;NT62NlE6PCEQvF2= NH3QbpRUSU6JRWK=
MLMA MWHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? M3TYemlEPTB;NT64N|YxPiEQvF2= NXLTZpllW0GQR1XS
RVH-421 MXLHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? M3PVNWlEPTB;Nj6wO|M{QCEQvF2= MnLJV2FPT0WU
LB1047-RCC M3;rWmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MYjJR|UxRTZwMUe1NlIh|ryP M{\hS3NCVkeHUh?=
MHH-NB-11 MUDHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? M3XjR2lEPTB;Nj6zNlczOSEQvF2= NX\wPY46W0GQR1XS
J-RT3-T3-5 NXLaWI5jT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= M373T2lEPTB;Nj62N|I6OSEQvF2= M3HwcXNCVkeHUh?=
UM-UC-3 NUTQXop6T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MUHJR|UxRTZwNkSzN|Qh|ryP NUnkcoM4W0GQR1XS
IST-SL1 M1:2cWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NHn0OpVKSzVyPU[uOlk{PjlizszN NEXqc|BUSU6JRWK=
NB14 NW\vUZdUT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NUXjO2lDUUN3ME22Mlc6PzZzIN88US=> MmHBV2FPT0WU
NBsusSR NYi3ZYhST3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NEnqOJpKSzVyPU[uPFI2ODJizszN M2P5SHNCVkeHUh?=
D-263MG M4jlfGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NYf4XJVxUUN3ME22MlkyODZ6IN88US=> NEfQ[XRUSU6JRWK=
NCI-H2347 M4K4TWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MUHJR|UxRTZwOUOyNVMh|ryP MY\TRW5ITVJ?
ES8 M3z1emdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MUnJR|UxRTZwOUe1PFgh|ryP MX3TRW5ITVJ?
786-0 M4HMc2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NIq3cGlKSzVyPUeuNFk4QDZizszN NHTCS45USU6JRWK=
EPLC-272H MkDpS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MonDTWM2OD15LkG2NlQ3KM7:TR?= MnPPV2FPT0WU
CAPAN-1 MoTlS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? M{PXNGlEPTB;Nz6yOFM2QSEQvF2= MkTvV2FPT0WU
NCI-H82 M1faN2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MVPJR|UxRTdwMk[2OVkh|ryP MX3TRW5ITVJ?
G-402 M1fDTWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 Ml:0TWM2OD15LkOwNFUyKM7:TR?= NW\MPVFvW0GQR1XS
SW982 M3\mR2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MoLWTWM2OD15LkOwNlA{KM7:TR?= MXrTRW5ITVJ?
OVCAR-4 MkjTS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MYLJR|UxRTdwM{GzNlgh|ryP NIPF[pZUSU6JRWK=
KARPAS-299 MX3Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NF3ybYhKSzVyPUeuN|I3OjJizszN MlmxV2FPT0WU
MIA-PaCa-2 MVHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MWLJR|UxRTdwM{[4NlMh|ryP NV\icIN2W0GQR1XS
AU565 NFzPRWVIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MXnJR|UxRTdwNUm4N|Mh|ryP NED3bHVUSU6JRWK=
GAMG M1ftXmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MoixTWM2OD15Lk[0NVMyKM7:TR?= M3ezXnNCVkeHUh?=
HuO9 NHTLNlVIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NXW4cZhSUUN3ME23MlcyPzR|IN88US=> Mm[wV2FPT0WU
ACN M{jE[mdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MWrJR|UxRTdwN{SzN{DPxE1? M{XLeXNCVkeHUh?=
RO82-W-1 M3HreWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 Ml;jTWM2OD15Lke0OVM{KM7:TR?= NXnlN5pCW0GQR1XS
NKM-1 MkHvS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MW\JR|UxRTdwN{S5OVUh|ryP MV\TRW5ITVJ?
CAL-12T Mkm0S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NYDsWFkyUUN3ME23Mlk1OzV{IN88US=> MVHTRW5ITVJ?
FADU M4fMbGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NHrrcFJKSzVyPUiuNFM3PTRizszN M3TrWHNCVkeHUh?=
NCI-H28 NIW4RWdIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NHfyToJKSzVyPUiuNVY6PjJizszN MXnTRW5ITVJ?
LCLC-97TM1 M1rVbGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NEH1O29KSzVyPUiuNlEyOjJizszN NFO5NGxUSU6JRWK=
CHP-134 NFTKS5ZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MXfJR|UxRThwMkSxPFUh|ryP NIjJbHNUSU6JRWK=
HT-1080 M4XEXmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NWnXVINoUUN3ME24MlI2ODl|IN88US=> NInZdWlUSU6JRWK=
PC-3 MWnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NG\mWIRKSzVyPUiuNlc{QTJizszN MlnpV2FPT0WU
SNU-449 NX;yU4xMT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= M3T0e2lEPTB;OD6yO|k{KM7:TR?= MoLwV2FPT0WU
VA-ES-BJ Mkm4S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MkCwTWM2OD16LkO0Olg3KM7:TR?= M{Dh[HNCVkeHUh?=
HT MoXvS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MoTrTWM2OD16LkO2OFkh|ryP NFHRNGpUSU6JRWK=
HOS Moi3S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MWnJR|UxRThwM{e1PFkh|ryP NX;mUFhzW0GQR1XS
KNS-62 M33XdWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MVrJR|UxRThwM{e3OlIh|ryP NEj1dFFUSU6JRWK=
OAW-42 M2DNRWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NHTqdmdKSzVyPUiuPVU6PjRizszN NUX6XHJIW0GQR1XS
A549 NUTtNlJiT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= M2DYcmlEPTB;OT6wPVYyOiEQvF2= MWPTRW5ITVJ?
CAKI-1 MmHzS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MXLJR|UxRTlwMU[2NUDPxE1? Mn:wV2FPT0WU
HCC1937 NHvqPXlIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MX3JR|UxRTlwNkm4OlUh|ryP M4jCPXNCVkeHUh?=
GI-ME-N NXXLTGdqT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NIPPbHhKSzVyPUmuO|AyOzdizszN NWfFPYFZW0GQR1XS
DU-4475 MV\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NHvPPFFKSzVyPUmuPVY6OzlizszN M3\1XnNCVkeHUh?=
EM-2 M4[3NWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NGnPfXNKSzVyPUGwMlI1OjZizszN M4TCUnNCVkeHUh?=
NCI-H1755 M12yc2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 Ml7UTWM2OD1zMD6yOFI5KM7:TR?= NIX0dZNUSU6JRWK=
NCI-H1437 NEG2RVhIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= Mn3zTWM2OD1zMD61O|I2KM7:TR?= M4n4SXNCVkeHUh?=
VM-CUB-1 NIrxeWdIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NIXjV4lKSzVyPUGwMlYyPjRizszN NH:5e3BUSU6JRWK=
A2058 NGjoXlRIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MkjlTWM2OD1zMD62OFA1KM7:TR?= NWiwXJB2W0GQR1XS
BPH-1 MVXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? M1HtXGlEPTB;MUCuO|E1PSEQvF2= M1fGOHNCVkeHUh?=
NB5 NWr0S49HT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MWjJR|UxRTFyLke1OVkh|ryP M3W1VHNCVkeHUh?=
G-401 MXLHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? M2PjcWlEPTB;MUCuO|YzPiEQvF2= MX\TRW5ITVJ?
CAL-72 M2ixd2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 M2\RVWlEPTB;MUCuPFA6PCEQvF2= M3P4NXNCVkeHUh?=
SK-MEL-28 Ml;MS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MVXJR|UxRTFyLkiyNFIh|ryP M{nNWXNCVkeHUh?=
C32 NXTYZpk2T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= M4fDfmlEPTB;MUCuPFM1PyEQvF2= MlvtV2FPT0WU
NCI-H1155 NF\6cYZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NGH6dItKSzVyPUGwMlg{PzZizszN NEfUfFBUSU6JRWK=
BB49-HNC M{Xm[mdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MU\JR|UxRTFyLki1PFYh|ryP NI[zXnVUSU6JRWK=
GMS-10 M3ixTmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MmHzTWM2OD1zMD64PVcyKM7:TR?= M2jwW3NCVkeHUh?=
K5 MnfjS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NH:1NlZKSzVyPUGwMlkxPzFizszN NHfCVWVUSU6JRWK=
OS-RC-2 MmHhS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NVXSUWxLUUN3ME2xNU4xPTV7IN88US=> NX7oRVVJW0GQR1XS
HTC-C3 NUHWcpB2T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MYDJR|UxRTFzLkC3NVQh|ryP M1zXVHNCVkeHUh?=
LB996-RCC Mom0S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NIrLNmtKSzVyPUGxMlA4OjNizszN NGTpPVlUSU6JRWK=
NCI-H1563 MnX1S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MkjZTWM2OD1zMT6xNFEyKM7:TR?= MX7TRW5ITVJ?
CAL-54 M1LmdGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NX;ae5pxUUN3ME2xNU41QDFzIN88US=> NX74OY01W0GQR1XS
WM-115 NXTKV3ZWT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NEXudWFKSzVyPUGxMlY5OjRizszN Mn3uV2FPT0WU
COLO-684 MnXKS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NWXFd3BqUUN3ME2xNU44OjZ5IN88US=> Mk\WV2FPT0WU
HOP-62 MmPiS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NEHkR4FKSzVyPUGxMlc2ODhizszN NG\tbHNUSU6JRWK=
NCI-H650 NFK3S5RIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= M3jydmlEPTB;MUGuPFk3OSEQvF2= NWSzUI42W0GQR1XS
TE-11 Ml3US5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? M2jwWmlEPTB;MUGuPVMyPSEQvF2= M4DqTXNCVkeHUh?=
COLO-679 MXXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MUnJR|UxRTFzLkm0OkDPxE1? MWrTRW5ITVJ?
FTC-133 NVriN3VVT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NYnn[4Y{UUN3ME2xNk4xODd4IN88US=> MVvTRW5ITVJ?
D-283MED NUHjSmZIT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MWrJR|UxRTF{LkC1Olkh|ryP M4LsXXNCVkeHUh?=
SK-PN-DW NFrj[2VIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NE\wbWZKSzVyPUGyMlE6ODJizszN NX7hcG1qW0GQR1XS
BALL-1 M2mycWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NET2SW9KSzVyPUGyMlI3PjJizszN M1rBdnNCVkeHUh?=
GT3TKB NGDIb2dIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NGXVOI5KSzVyPUGyMlMxPzRizszN M17aS3NCVkeHUh?=
HOP-92 MV\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? M2XPbmlEPTB;MUKuOVI{OyEQvF2= NXTXVVM4W0GQR1XS
M14 Ml3IS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? Mkf5TWM2OD1zMz6wN|M2KM7:TR?= NVjhVXRRW0GQR1XS
SKG-IIIa Mmj4S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NGK3SnpKSzVyPUGzMlA2PTRizszN MmPDV2FPT0WU
Becker M3rETGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MlmwTWM2OD1zMz6wOVgh|ryP NY\NVnE4W0GQR1XS
ES5 NUTZW3VWT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NG\YRVFKSzVyPUGzMlE{PTZizszN MWPTRW5ITVJ?
NCI-H2030 NEjPN5JIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NUHHeGpkUUN3ME2xN{4zODZ{IN88US=> NHjieYFUSU6JRWK=
SNU-423 NEX3cWRIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MUfJR|UxRTF|LkO4NUDPxE1? NUP0OVM2W0GQR1XS
CP50-MEL-B NEOzNllIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MmXTTWM2OD1zMz62NlMzKM7:TR?= M4fHZnNCVkeHUh?=
NCI-H1092 MXvHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MYTJR|UxRTF|Lke0O|Uh|ryP MXHTRW5ITVJ?
8-MG-BA NXL4bW9jT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NFP1TIdKSzVyPUGzMlc2OTNizszN NHfzTIlUSU6JRWK=
CAL-27 NYX6XIJnT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MYDJR|UxRTF2LkC3Nlch|ryP M2XW[nNCVkeHUh?=
AGS NVL0W4pyT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MXjJR|UxRTF2LkGzNVkh|ryP MVvTRW5ITVJ?
MZ2-MEL NV7IWXBNT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NXHSSXNlUUN3ME2xOE4yPDh6IN88US=> MVfTRW5ITVJ?
BFTC-909 NV\iO|ZKT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= M4fjTGlEPTB;MUSuOVA2PSEQvF2= NYjwSVhMW0GQR1XS
D-566MG NHntTYhIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NITJcJRKSzVyPUG0Mlc4ODZizszN NWPRSphMW0GQR1XS
MZ7-mel NEn4OIpIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MlvzTWM2OD1zNT6xNFY4KM7:TR?= NWTPWmpWW0GQR1XS
TE-5 MUXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MkH0TWM2OD1zNT6yN|M{KM7:TR?= Mn64V2FPT0WU
647-V MknoS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? M4LucWlEPTB;MUWuNlcxPSEQvF2= M2TlWnNCVkeHUh?=
DMS-114 MlTnS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NHnw[JRKSzVyPUG1MlMzQTFizszN NWPvbmVjW0GQR1XS
ME-180 NXO1R3ZqT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MmfKTWM2OD1zNT60O|g{KM7:TR?= NEDZT4RUSU6JRWK=
MS-1 M1jLeGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MnzKTWM2OD1zNT61OlI{KM7:TR?= MXvTRW5ITVJ?
NUGC-3 MoXaS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NYLHV|c1UUN3ME2xOU43OjR3IN88US=> MlvxV2FPT0WU
GB-1 M2DEWGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NGj1c29KSzVyPUG1MlY1OzdizszN NVv6Z|Z4W0GQR1XS
LOXIMVI MX;Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NFHsUWJKSzVyPUG1Mlg6OTlizszN NV7yXnpuW0GQR1XS
NCI-H1304 Mon6S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MYXJR|UxRTF3Lki5Nlgh|ryP NIHofoNUSU6JRWK=
KURAMOCHI NXuzfY82T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MlfPTWM2OD1zNT65O|Eh|ryP NHfrO2hUSU6JRWK=
SW1783 M3\Wemdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NUnaUGpSUUN3ME2xOk4xQTl|IN88US=> MX3TRW5ITVJ?
EGI-1 MWjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? M3HEcmlEPTB;MU[uOVM3PSEQvF2= MXPTRW5ITVJ?
KGN NFLvbWNIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NWPrb4RmUUN3ME2xOk42PTh4IN88US=> NV;PfJVGW0GQR1XS
PANC-03-27 MlnvS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MmrBTWM2OD1zNj63OlYzKM7:TR?= M2HUSnNCVkeHUh?=
RH-1 M1:1cGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NVGw[IRoUUN3ME2xOk45OjVizszN M{nPVHNCVkeHUh?=
HT-1376 MkO3S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MUfJR|UxRTF4Lki0OFYh|ryP NWXjSWNLW0GQR1XS
ZR-75-30 M1XoSmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NHr3bYRKSzVyPUG2Mlk{PjFizszN NGOyOpVUSU6JRWK=
TI-73 NEnJ[o9Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?= M4XxfmlEPTB;MU[uPVQxQCEQvF2= MV3TRW5ITVJ?
TK10 Mk\jS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NHXqUohKSzVyPUG3MlAxPzlizszN MnLIV2FPT0WU
SW684 NVvkd|B6T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MnHNTWM2OD1zNz6wNVU1KM7:TR?= NVzyd|M5W0GQR1XS
RPMI-8866 NGHSdmtIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NIXId3JKSzVyPUG3MlA3QTlizszN NH7xO45USU6JRWK=
LNCaP-Clone-FGC M{\mc2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MnLwTWM2OD1zNz61NlAyKM7:TR?= NF3BZlJUSU6JRWK=
NCI-H2291 NF3GXJNIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MWrJR|UxRTF6LkSzOFUh|ryP NHnQ[odUSU6JRWK=
T47D NHLnXFVIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NX7WeoJ2UUN3ME2xPE41QDhizszN MnW0V2FPT0WU
A204 NV7rVphzT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MlTDTWM2OD1zOD61OFUzKM7:TR?= NF;pXVhUSU6JRWK=
HT-144 Mo\vS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? M4XTTmlEPTB;MUiuO|QzPyEQvF2= NFTtbIFUSU6JRWK=
MDA-MB-361 NITjXohIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MX\JR|UxRTF7LkC3NVQh|ryP MnTIV2FPT0WU
HCC1806 MnSyS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MX\JR|UxRTF7LkG1PVEh|ryP MWfTRW5ITVJ?
NCI-H596 NWDOdphFT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= M3Tmc2lEPTB;MUmuOlM6OSEQvF2= M4LVdHNCVkeHUh?=
K-562 MkDlS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NYXKSFlIUUN3ME2xPU45QTJ4IN88US=> NHXKTJlUSU6JRWK=
D-336MG NV7BdHZoT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NIrieZlKSzVyPUG5Mlk{OjJizszN MYDTRW5ITVJ?
SK-MEL-2 NF:zN5FIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MXfJR|UxRTJyLkG1OVkh|ryP NG\IeGJUSU6JRWK=
HEC-1 NFS0TYxIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NVy4R2tFUUN3ME2yNE41QTd6IN88US=> NWHLU2lWW0GQR1XS
EW-13 NH\nfoZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MXfJR|UxRTJyLkW0OFMh|ryP M1jsPHNCVkeHUh?=
Hs-578-T MWXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NXvzVFQxUUN3ME2yNE42PTh|IN88US=> Ml;4V2FPT0WU
SJSA-1 NEf3UItIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MoXjTWM2OD1{MD61Olg5KM7:TR?= Ml3SV2FPT0WU
RCC10RGB NWnkSmdLT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MkfJTWM2OD1{MD62O|E6KM7:TR?= MnfRV2FPT0WU
LAN-6 M1\HfWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 M4O1S2lEPTB;MkGuNFM6PiEQvF2= NVKyNFNPW0GQR1XS
NCI-H1048 MYHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NILLR5dKSzVyPUKxMlIzPThizszN M1P3WHNCVkeHUh?=
CW-2 NE\XOZZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MkHSTWM2OD1{MT6yO|A2KM7:TR?= MWnTRW5ITVJ?
HCC2157 MV\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NHnQTopKSzVyPUKxMlM3KM7:TR?= NHzFSY5USU6JRWK=
EW-22 NHzV[ZlIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= M1XpOmlEPTB;MkGuN|c3KM7:TR?= NV\FOlNXW0GQR1XS
A253 NHmzcIhIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= M{LU[2lEPTB;MkGuOFQ5OSEQvF2= MU\TRW5ITVJ?
BE-13 NVTBVlltT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= M3XpV2lEPTB;MkGuOlEyOyEQvF2= NGPRNYtUSU6JRWK=
KINGS-1 NIraTXhIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MXLJR|UxRTJzLk[zNVYh|ryP NInNSWJUSU6JRWK=
ETK-1 MlPyS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NV7IXow5UUN3ME2yNU45OTV{IN88US=> NY\zZWZ[W0GQR1XS
NCI-H2452 MlPUS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NYLaTZdnUUN3ME2yNU45PjR5IN88US=> NVXQfJpwW0GQR1XS
HPAF-II MWjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NVj4UFhiUUN3ME2yNU45QTJ|IN88US=> M1XISXNCVkeHUh?=
D-542MG M4jFfWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MV3JR|UxRTJzLkmwOlkh|ryP NGDLVpRUSU6JRWK=
NCI-H630 NWDnXHExT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= M{TzNGlEPTB;MkKuNFI6PiEQvF2= MYPTRW5ITVJ?
TGBC11TKB M1rJUGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NYPteHpIUUN3ME2yNk4xPDlizszN M{DlXXNCVkeHUh?=
BCPAP MmWyS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NHfy[VlKSzVyPUKyMlYyOSEQvF2= NXvxR4VOW0GQR1XS
HLE M{nHPGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NXvyeIgxUUN3ME2yNk43QTdizszN NFXpOlNUSU6JRWK=
NCI-H727 NI\L[GVIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= Mn\OTWM2OD1{Mj63N|Uh|ryP NWHvfGh4W0GQR1XS
RD MVTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? M4fHXWlEPTB;MkKuO|UyQCEQvF2= MXPTRW5ITVJ?
NCI-H522 MVfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NXfQZXozUUN3ME2yNk45PDNzIN88US=> NGrmcXJUSU6JRWK=
CGTH-W-1 NGnnSVJIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= M1m5NGlEPTB;MkOuNFY1OSEQvF2= MYrTRW5ITVJ?
SK-LU-1 NVrab5V2T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= M3jlcWlEPTB;MkOuOFY5OyEQvF2= NXXrTZg2W0GQR1XS
BB65-RCC M{XrZmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MnrWTWM2OD1{Mz63PFY{KM7:TR?= NIjacYpUSU6JRWK=
HSC-3 MoDUS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NYjweYY2UUN3ME2yN{45PTJ5IN88US=> NVfHUZNVW0GQR1XS
SK-MES-1 NGDPeWpIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NF3FbmFKSzVyPUK0MlAyPjFizszN MVLTRW5ITVJ?
DB NXzPXoVJT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MmTqTWM2OD1{ND6xNFI5KM7:TR?= M37BRnNCVkeHUh?=
HO-1-N-1 MWXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MYTJR|UxRTJ2LkOwPVMh|ryP M2LmRXNCVkeHUh?=
MKN1 MXzHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MonBTWM2OD1{ND62PEDPxE1? MVjTRW5ITVJ?
MN-60 MWfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MXnJR|UxRTJ2Lki1NVkh|ryP Mly1V2FPT0WU
8505C NYjHdJZ3T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MYXJR|UxRTJ3LkG4OFUh|ryP MWXTRW5ITVJ?
COLO-320-HSR NHXCZVRIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NVfaTHI6UUN3ME2yOU4zOjB6IN88US=> MmH4V2FPT0WU
BB30-HNC MlrsS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NWnsdo5RUUN3ME2yOU4zPDh|IN88US=> M4W1bHNCVkeHUh?=
KM12 M3mwcGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MlOyTWM2OD1{NT61PFA4KM7:TR?= NV3KSnFnW0GQR1XS
NB13 NIT5dG1Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?= Mof4TWM2OD1{NT61PFk5KM7:TR?= MW\TRW5ITVJ?
HCC2998 NXjhflk3T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NG\EXHpKSzVyPUK2MlAzQDNizszN NWr2VpJvW0GQR1XS
U-118-MG NX7PRoNoT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NWnCUYtSUUN3ME2yOk4xQDB6IN88US=> MlXxV2FPT0WU
NB10 NVP3UnV4T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NXKwNFBDUUN3ME2yOk4zOzRizszN MonmV2FPT0WU
SK-LMS-1 NX;YWGZ6T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NXHBb2lVUUN3ME2yO{4xPzB2IN88US=> MX\TRW5ITVJ?
SW1573 MXnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MXHJR|UxRTJ5LkGxJO69VQ>? MUnTRW5ITVJ?
LB373-MEL-D MoXJS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? M1nlN2lEPTB;MkeuNVI6PCEQvF2= MmL3V2FPT0WU
DK-MG M{n4WWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 M1TFPGlEPTB;MkeuNVgyPyEQvF2= M{PJZ3NCVkeHUh?=
RMG-I MX\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MofXTWM2OD1{Nz6yNFI6KM7:TR?= M{fkUnNCVkeHUh?=
SW1088 M3Tnb2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MUTJR|UxRTJ5LkWwOFIh|ryP MWPTRW5ITVJ?
SK-OV-3 MVTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? M1zLNWlEPTB;MkeuO|U6OyEQvF2= MljyV2FPT0WU
KP-N-YN MV;Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? M3PmUGlEPTB;MkeuPFA1OyEQvF2= NUjVU4dEW0GQR1XS
RPMI-7951 NF3ab5ZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MXPJR|UxRTJ6LkK0OVYh|ryP NIPveXZUSU6JRWK=
CaR-1 NV3QRldmT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= M3fxfmlEPTB;MkiuOVU5OiEQvF2= M1HmcHNCVkeHUh?=
MKN7 MX7Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MVfJR|UxRTJ6LkW5OlQh|ryP MmnLV2FPT0WU
CHP-212 MUfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MVvJR|UxRTJ6Lke0NFEh|ryP MnnBV2FPT0WU
KYSE-450 NXfqc41WT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= M4LDb2lEPTB;MkiuPFA6OSEQvF2= MWfTRW5ITVJ?
RXF393 NECwbmNIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MWjJR|UxRTJ7LkK5NFYh|ryP M13ENHNCVkeHUh?=
P30-OHK M{XjXmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MVfJR|UxRTJ7LkOwOFgh|ryP MoXxV2FPT0WU
Ca9-22 NFX4NVdIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= Mmf4TWM2OD1{OT60Nlk6KM7:TR?= MmK3V2FPT0WU
RT-112 M4TwT2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MUnJR|UxRTJ7LkS2NVEh|ryP NVjn[ol3W0GQR1XS
ES1 MUnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NYHQW3FYUUN3ME2yPU45PTR2IN88US=> MkP3V2FPT0WU
HCE-4 NXWyb|J{T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MWHJR|UxRTJ7Lki3PFYh|ryP Ml\0V2FPT0WU
AM-38 NEXCTJlIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MmPXTWM2OD1|MD6wOlA3KM7:TR?= MmPRV2FPT0WU
AsPC-1 M1PEW2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MXrJR|UxRTNyLkiwOVMh|ryP M3v1bnNCVkeHUh?=
TE-9 NHjSOnZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MVrJR|UxRTNyLki3N|ch|ryP MVPTRW5ITVJ?
HuP-T4 M3fjSmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NILibFdKSzVyPUOwMlk3OzhizszN MY\TRW5ITVJ?
LB2518-MEL MmTLS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NVvqUpl2UUN3ME2zNU4xPzR2IN88US=> MonHV2FPT0WU
NCI-H1703 NHG2WmVIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MXfJR|UxRTNzLkC5NFUh|ryP NFrjc45USU6JRWK=
NCI-H2228 NHzjbItIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NXf2TWtbUUN3ME2zNU41PjVzIN88US=> MXXTRW5ITVJ?
SCC-4 NGf0UFNIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MYXJR|UxRTNzLkmxPFEh|ryP NEHSeIJUSU6JRWK=
KNS-81-FD MlLXS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? M1v0SWlEPTB;M{KuNFEzQCEQvF2= NGTvTHNUSU6JRWK=
NTERA-S-cl-D1 M{jxdGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NYT2cmx4UUN3ME2zNk4xPzN7IN88US=> MoW3V2FPT0WU
Daoy MmLaS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? M4rYPWlEPTB;M{KuNFg{QCEQvF2= NV\YSXNpW0GQR1XS
ES4 NILyW45Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NEfIR3RKSzVyPUOyMlM6OjJizszN NELjboZUSU6JRWK=
MHH-ES-1 M3nYRmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NVvOcoVkUUN3ME2zNk41QDd{IN88US=> NF\S[2dUSU6JRWK=
C-33-A M2XCN2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MYnJR|UxRTN{Lke3Nlgh|ryP NWrPSlBqW0GQR1XS
BHY MnXLS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? M1PHPGlEPTB;M{KuPVQ6PSEQvF2= NH;nNWxUSU6JRWK=
Detroit562 MUDHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NYryR2JuUUN3ME2zN{43PjV5IN88US=> NGDuWohUSU6JRWK=
EW-1 NEW5[4lIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MUPJR|UxRTN|LkmzNlIh|ryP MUDTRW5ITVJ?
NCI-H1395 MWjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NFP4bJZKSzVyPUO0MlA4QTlizszN NETGVYlUSU6JRWK=
KM-H2 MYXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MXzJR|UxRTN4LkS3OFMh|ryP MmXaV2FPT0WU
NCI-H520 NV3HNGVKT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= M{[zdmlEPTB;M{[uO|U1OSEQvF2= MXXTRW5ITVJ?
D-392MG Mn\MS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MlzkTWM2OD1|Nz6zN|Q1KM7:TR?= NVfMT4tpW0GQR1XS
NOMO-1 MXnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NF:1NVJKSzVyPUO3MlgxQDlizszN Ml;6V2FPT0WU
TE-6 Mn3qS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NYfFb|ZDUUN3ME2zPE4yOjRizszN NYHpNpo{W0GQR1XS
HT-3 NHTGN4xIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= M{jmeGlEPTB;M{iuOFQ{PiEQvF2= M1:xOHNCVkeHUh?=
RPMI-8226 NWe1UJZ4T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NHrReXJKSzVyPUO4Mlk2OTlizszN NVvrVJBrW0GQR1XS
U251 MlKyS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NGfIN5JKSzVyPUO5MlAyOjRizszN NHnhVI1USU6JRWK=
GCT NYTqd4xmT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NELhOXRKSzVyPUO5MlE5PTJizszN NYPI[4Z5W0GQR1XS
A431 NGLTe2JIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NF23Nm5KSzVyPUO5MlE5QTRizszN MoTkV2FPT0WU
TE-12 NHzuS5VIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MV7JR|UxRTN7LkK0OFgh|ryP MXTTRW5ITVJ?
HMV-II MVnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? M2job2lEPTB;M{muOVA1PyEQvF2= M2rJNXNCVkeHUh?=
IST-MES1 NX\RZ|gxT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NWWyV|h2UUN3ME20NE4yPTB{IN88US=> Mly1V2FPT0WU
SW13 NELnR3lIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NEj3RmtKSzVyPUSwMlUyQSEQvF2= MVzTRW5ITVJ?
SF295 M4\iXWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NEjk[GlKSzVyPUSwMlgxPjZizszN MUjTRW5ITVJ?
MDA-MB-157 MV\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NFzrWpRKSzVyPUSwMlk1PjJizszN M4HqW3NCVkeHUh?=
TE-1 MWfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NXX4end3UUN3ME20NU45PzF2IN88US=> MkLwV2FPT0WU
HuCCT1 MYHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? M1TYbGlEPTB;NEKuOVI5QSEQvF2= MlPGV2FPT0WU
KYSE-510 M{DLZWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MmPjTWM2OD12Mz6xO|U1KM7:TR?= MV3TRW5ITVJ?
NCI-H358 MoPhS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? M{HzbmlEPTB;NESuNFMxPCEQvF2= MWPTRW5ITVJ?
SW900 M37NV2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 Ml\WTWM2OD12ND6wO|U5KM7:TR?= NHjjdmdUSU6JRWK=
CAS-1 MXfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? Mke4TWM2OD12ND6wPVkyKM7:TR?= MWXTRW5ITVJ?
TE-8 NXTDVY9KT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NUGzR3J6UUN3ME20OE42PjV6IN88US=> MnLYV2FPT0WU
P12-ICHIKAWA MWrHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? Mln1TWM2OD12ND62NVEzKM7:TR?= M1f0fHNCVkeHUh?=
YKG-1 MVXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? M3fRO2lEPTB;NESuO|gyKM7:TR?= M4HXSnNCVkeHUh?=
SNU-C2B MV\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NVznfmIyUUN3ME20OE44QTB|IN88US=> Mnm2V2FPT0WU
LCLC-103H MYXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NGnMXmpKSzVyPUS0Mlg4ODNizszN NXuz[mFNW0GQR1XS
U-87-MG MVPHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MmLmTWM2OD12NT6xNFIzKM7:TR?= MnzjV2FPT0WU
HAL-01 M4iwVmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NUf1TpZ4UUN3ME20OU4yOzd7IN88US=> NHfHUnVUSU6JRWK=
OVCAR-8 M1\hNmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NXfzRXdQUUN3ME20OU4{PTZ2IN88US=> NFztfVBUSU6JRWK=
KYSE-150 M3nke2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MmDsTWM2OD12Nz6xNFUzKM7:TR?= Moj5V2FPT0WU
OE33 MojWS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NEXCW|lKSzVyPUS3MlE1OjlizszN M{\EWnNCVkeHUh?=
CAL-62 MVvHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? M1G0ZWlEPTB;NEeuOFA3QCEQvF2= NGjzTWxUSU6JRWK=
TCCSUP NFPDNYlIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= Mn\VTWM2OD12Nz62NlY1KM7:TR?= NIDx[|BUSU6JRWK=
H4 M4CwW2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 Mm[zTWM2OD12Nz62OlIyKM7:TR?= NXji[FVSW0GQR1XS
CP66-MEL M{PzOWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 Ml;DTWM2OD12OD6wO|A1KM7:TR?= NVHFPIpPW0GQR1XS
SNB75 MX\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? Mn;XTWM2OD12OD6xPFc1KM7:TR?= M3XFXXNCVkeHUh?=
Mo-T MUHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NVTHU4hqUUN3ME20PE4zPzlizszN NEHiVVRUSU6JRWK=
BT-549 Ml36S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? Ml7OTWM2OD12OD6zO|I6KM7:TR?= MX\TRW5ITVJ?
IGR-1 Mnz0S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? M4e4UWlEPTB;NEiuOlY1PSEQvF2= NIDze3FUSU6JRWK=
NCI-H1299 MmPkS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MXjJR|UxRTR6LkeyOFgh|ryP M{PIU3NCVkeHUh?=
ALL-PO NXeyVGY4T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MkLJTWM2OD12OT65NlY5KM7:TR?= NV3sXm9rW0GQR1XS

... Click to View More Cell Line Experimental Data

In vivo NU7441 intraperitoneally administrated at dose of 10 mg/kg maintains for at least 4 hours shows nontoxic and increases etoposide-induced tumor growth delay 2-fold in mice bearing SW620 xenografts. [2]

Protocol

Cell Research:

[2]

+ Expand
  • Cell lines: SW620, LoVo, V3-YAC and V3 cells
  • Concentrations: 0.5 μM or 1 μM
  • Incubation Time: 17 hours
  • Method:

    The effect of NU7441 on cellular survival following exposure to etoposide, doxorubicin, and ionizing radiation is measured in SW620, LoVo, V3, and V3-YAC cells by clonogenic assays. Briefly, growing cells in six-well plates or 6-cm dishes are exposed to etoposide or doxorubicin with or without NU7441 (0.5 or 1.0 μM) for 16 hours. For radiosensitization studies, NU7441 is added to the cells 1 hour before irradiation. V3 and V3-YAC cells are exposed to γ-irradiation (3.1 Gy/min 137Cesium). SW620 and LoVo are exposed to X-irradiation (2.9 Gy/min at 230 kV, 10 mA) due to the equipment available. After irradiation, the cells are incubated with or without NU7441 for a further 16 hours. Cells are then harvested by trypsinization, counted, and seeded into 10-cm diameter Petri dishes at densities varying from 100 to 105 per dish in drug-free medium for colony formation. Colonies are stained with crystal violet after 10 to 14 days and counted with an automated colony counter. The survival reduction factor (SRF) is calculated as the surviving fraction of cells in the absence of NU7441 divided by the surviving fraction of cells in the presence of NU7441 for any given dose or concentration of cytotoxic agent. The dose modification ratio (DMR90) is calculated as the concentration/dose of cytotoxic agent required to kill 90% of the cells in the absence of NU7441 divided by the concentration/dose of cytotoxic agent required to kill 90% of the cells in the presence of NU7441.


    (Only for Reference)
Animal Research:

[2]

+ Expand
  • Animal Models: Female rude mice bearing SW620 xenografts
  • Formulation: Sterile 0.9% sodium chloride solution
  • Dosages: 10 mg/kg
  • Administration: Intraperitoneally administrated
    (Only for Reference)

Solubility (25°C)

In vitro DMSO 4 mg/mL warmed (9.67 mM)
Water Insoluble
Ethanol Insoluble
In vivo Add solvents to the product individually and in order(Data is from Selleck tests instead of citations):
5% DMSO+30% PEG 300+5% Tween 80+ddH2O
For best results, use promptly after mixing.
2mg/mL

* Please note that Selleck tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations.

Chemical Information

Molecular Weight 413.49
Formula

C25H19NO3S

CAS No. 503468-95-9
Storage powder
in solvent
Synonyms N/A

Bio Calculators

Molarity Calculator

Molarity Calculator

Calculate the mass, volume or concentration required for a solution. The Selleck molarity calculator is based on the following equation:

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

  • Mass
    Concentration
    Volume
    Molecular Weight

*When preparing stock solutions, please always use the batch-specific molecular weight of the product found on the via label and MSDS / COA (available on product pages).

Dilution Calculator

Dilution Calculator

Calculate the dilution required to prepare a stock solution. The Selleck dilution calculator is based on the following equation:

Concentration (start) x Volume (start) = Concentration (final) x Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2 ( Input Output )

  • C1
    V1
    C2
    V2

* When preparing stock solutions always use the batch-specific molecular weight of the product found on the vial label and MSDS / COA (available online).

The Serial Dilution Calculator Equation

  • Serial Dilutions

  • Computed Result

  • C1=C0/X C1: LOG(C1):
    C2=C1/X C2: LOG(C2):
    C3=C2/X C3: LOG(C3):
    C4=C3/X C4: LOG(C4):
    C5=C4/X C5: LOG(C5):
    C6=C5/X C6: LOG(C6):
    C7=C6/X C7: LOG(C7):
    C8=C7/X C8: LOG(C8):
Molecular Weight Calculator

Molecular Weight Calculator

Enter the chemical formula of a compound to calculate its molar mass and elemental composition:

Total Molecular Weight: g/mol

Tip: Chemical formula is case sensitive. C10H16N2O2 c10h16n2o2

Instructions to calculate molar mass (molecular weight) of a chemical compound:

To calculate molar mass of a chemical compound, please enter its chemical formula and click 'Calculate'.

Definitions of molecular mass, molecular weight, molar mass and molar weight:

Molecular mass (molecular weight) is the mass of one molecule of a substance and is expressed in the unified atomic mass units (u). (1 u is equal to 1/12 the mass of one atom of carbon-12)
Molar mass (molar weight) is the mass of one mole of a substance and is expressed in g/mol.

Molarity Calculator

Mass Concentration Volume Molecular Weight

Tech Support

Answers to questions you may have can be found in the inhibitor handling instructions. Topics include how to prepare stock solutions, how to store inhibitors, and issues that need special attention for cell-based assays and animal experiments.

Handling Instructions

Tel: +1-832-582-8158 Ext:3

If you have any other enquiries, please leave a message.

  • * Indicates a Required Field

Frequently Asked Questions

  • Question 1:

    Could you please suggest formulations of the drug for in vivo injection?

  • Answer:

    We tested the following formulation for in vivo use, 4% DMSO+30% PEG 300+5% Tween 80+ddH2O up to 1mg/mL. It is a clear solution.

  • Question 2:

    Previous aliquots were clear and colorless while this time, it becomes yellow when the powder was dissolved in DMSO? Could you advice on this?

  • Answer:

    Slight color variation due to different processing is normal and usually doesn't interfere with the function.

DNA-PK Signaling Pathway Map

DNA-PK Inhibitors with Unique Features

Related DNA-PK Products4

Tags: buy NU7441 (KU-57788) | NU7441 (KU-57788) supplier | purchase NU7441 (KU-57788) | NU7441 (KU-57788) cost | NU7441 (KU-57788) manufacturer | order NU7441 (KU-57788) | NU7441 (KU-57788) distributor
×
Cell Lines Assay Type Concentration Incubation Time Formulation Activity Description PMID